NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 2.000

-0.5%

10:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: donpat who wrote (10993)

8/24/2018 10:43:21 AM

From: drkaz

Read Replies (2) of 12871

Sounds more than a bit like what International Stem Cell Corporation (ISCO) is trying to do. However, ISCO has already got a Parkinson's Disease treatment using their stem cell technology part way through a Phase I trial in Australia.

internationalstemcell.com

investors.internationalstemcell.com

Jun 11, 2018

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial

And

investors.internationalstemcell.com

Aug 06, 2018

International Stem Cell Corporation Developed 3D Liver Structures

At least with Diwan's micelle technology they are (were?) ahead of the curve in technology. With this idea they are years behind a potential competitor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next